Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 12, 2013, Pages 895-901

  Velarde Miranda, Carolina ^a,b   Gomez Sanchez, Elise P ^a,b   Gomez Sanchez, Celso E ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Alsdosterone; Angiotensin II; Intracellular calcium; KCNJ5; Kir3.4; Potassium channel

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; CALCIMYCIN; CALCIUM; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; HYDROCORTISONE;

ADRENAL CORTEX CARCINOMA; BIOSYNTHESIS; CALCIUM CELL LEVEL; DOWN REGULATION; GENE MUTATION; HYDROCORTISONE RELEASE; PRIMARY HYPERALDOSTERONISM; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; ZONA GLOMERULOSA;

ALSDOSTERONE; ANGIOTENSIN II; INTRACELLULAR CALCIUM; KCNJ5; KIR3.4; POTASSIUM CHANNEL;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; ANGIOTENSIN II; CELL MEMBRANE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; HYPERTENSION; MUTATION; POTASSIUM; ZONA GLOMERULOSA;

EID: 84888047497     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12151     Document Type: Review

References (45)

1. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2008; 93: 3266-81.
2. + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331: 768-72.
3. Akerstrom T, Crona J, Delgado Verdugo A et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE 2012; 7: e41926.
4. Boulkroun S, Beuschlein F, Rossi GP et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 2012; 59: 592-8.
5. Azizan EA, Murthy M, Stowasser M et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 2012; 59: 587-91.
6. Taguchi R, Yamada M, Nakajima Y et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 2012; 97: 1311-9.
7. Monticone S, Hattangady NG, Nishimoto K et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J. Clin. Endocrinol. Metab. 2012; 97: E1567-72.
8. Mulatero P, Tauber P, Zennaro MC et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 2012; 59: 235-40.
9. Scholla UI, Nelson-Williamsa C, Yuec P et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl Acad. Sci. USA 2012; 109: 2533-8.
10. Charmandari E, Sertedaki A, Kino T et al. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J. Clin. Endocrinol. Metab. 2012; 97: E1532-9.
11. Beuschlein F, Boulkroun S, Osswald A et al. Somatic Na+, K + -ATPase and Ca2 + -ATPase mutations leading to aldosterone producing adenomas and secondary hypertension. Nat. Genet. 2013; 45: 440-4.
12. Matthews EK, Saffran M. Effect of ACTH on the electrical properties of adrenocortical cells. Nature 1968; 219: 1369-70.
13. Matthews EK, Saffran M. Ionic dependence of adrenal steroidogenesis and ACTH-induced changes in the membrane potential of adrenocortical cells. J. Physiol. 1973; 234: 43-64.
14. + channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am. J. Physiol. Endocrinol. Metab. 2004; 287: E1154-65.
15. Nogueira EF, Gerry D, Mantero F, Mariniello B, Rainey WE. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin. Endocrinol. 2010; 73: 22-9.
16. Heitzmann D, Derand R, Jungbauer S et al. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 2008; 27: 179-87.
17. Guagliardo NA, Yao J, Hu C, Barrett PQ. Minireview: Aldosterone biosynthesis: Electrically gated for our protection. Endocrinology 2012; 153: 3579-86.
18. Hu C, Rusin CG, Tan Z, Guagliardo NA, Barrett PQ. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J. Clin. Invest. 2012; 122: 2046-53.
19. Guagliardo NA, Yao J, Hu C et al. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension 2012; 59: 999-1005.
20. Davies LA, Hu C, Guagliardo NA et al. TASK channel deletion in mice causes primary hyperaldosteronism. Proc. Natl Acad. Sci. USA 2008; 105: 2203-8.
21. + channel in adrenocortical cells is TREK-1. J. Biol. Chem. 2002; 277: 49186-99.
22. Czirjak G, Enyedi P. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol. Endocrinol. 2002; 16: 621-9.
23. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: A case study using the Phyre server. Nat. Protoc. 2009; 4: 363-71.
24. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: Their structure, function, and physiological roles. Physiol. Rev. 2010; 90: 291-366.
25. Kurachi Y, Ishii M. Cell signal control of the G protein-gated potassium channel and its subcellular localization. J. Physiol. 2004; 554: 285-94.
26. + channels to plasma membrane in endocrine cells. J. Biol. Chem. 1999; 274: 7969-74.
27. Gregerson KA, Flagg TP, O'Neill TJ et al. Identification of G protein-coupled, inward rectifier potassium channel gene products from the rat anterior pituitary gland. Endocrinology 2001; 142: 2820-32.
28. Wu KD, Chen YM, Chu TS et al. Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma. Am. J. Hypertens. 2002; 15: 609-14.
29. + channels. Science 1992; 258: 1152-5.
30. Boulkroun S, Golib Dzib JF, Samson-Couterie B et al. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling. Mol. Cell. Endocrinol. 2013; 371: 221-7.
31. Oki K, Plonczynski MW, Lam ML, Gomez-Sanchez EP, Gomez-Sanchez CE. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line. Endocrinology 2012; 153: 4328-35.
32. Yow TT, Pera E, Absalom N et al. Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. Br. J. Pharmacol. 2011; 163: 1017-33.
33. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 2008; 93: 3117-23.
34. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE. Potassium channel mutant KCNJ5T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 2012; 153: 1774-82.
35. Mulatero P, di Cella SM, Monticone S et al. 18-Hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J. Clin. Endocrinol. Metab. 2012; 97: 881-9.
36. + channel and gating regulation by G proteins, PIP2, and sodium. Cell 2011; 147: 199-208.
37. Murthy M, Azizan EA, Brown MJ, O'Shaughnessy KM. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J. Hypertens. 2012; 30: 1827-33.
38. McCoy JG, Nimigean CM. Structural correlates of selectivity and inactivation in potassium channels. Biochim. Biophys. Acta 2012; 1818: 272-85.
39. Williams TA, Monticone S, Crudo V, Warth R, Veglio F, Mulatero P. VSNL1 is upregulated in aldosterone producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension 2012; 59: 833-9.
40. Boulkroun S, Samson-Couterie B, Golib-Dzib JF et al. Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology 2011; 152: 4753-63.
41. Boulkroun S, Samson-Couterie B, Dzib JF et al. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension 2010; 56: 885-92.
42. Nishimoto K, Nakagawa K, Li D et al. Adrenocortical zonation in humans under normal and pathological conditions. J. Clin. Endocrinol. Metab. 2010; 95: 2296-305.
43. Nanba K, Tsuiki M, Sawai K et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J. Clin. Endocrinol. Metab. 2013; 98: 1567-74.
44. Volpe C, Hoog A, Ogishima T et al. Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism. J. Clin. Pathol. 2013; 66: 351-4.
45. Seccia TM, Mantero F, Letizia C et al. Somatic mutations in the KCNJ5 gene raise the lateralization index: Implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J. Clin. Endocrinol. Metab. 2012; 97: E2307-13.